O'Leary JG - Search Results

1

Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter Study.

Verna EC, Saxena V, Burton JR Jr, O'Leary JG, Dodge JL, Stravitz RT, Levitsky J, Trotter JF, Everson GT, Brown RS Jr, Terrault NA; CRUSH-C Consortium. Verna EC, et al. Transplantation. 2015 Aug;99(8):1644-51. doi: 10.1097/TP.0000000000000629. Transplantation. 2015. PMID: 25715116 Free PMC article.

2

Post-liver transplant survival in hepatitis C patients is improving over time.

O'Leary JG, Randall H, Onaca N, Jennings L, Klintmalm GB, Davis GL. O'Leary JG, et al. Liver Transpl. 2009 Apr;15(4):360-8. doi: 10.1002/lt.21691. Liver Transpl. 2009. PMID: 19326409 Free article.

3

Conivaptan increases serum sodium in hyponatremic patients with end-stage liver disease.

O'Leary JG, Davis GL. O'Leary JG, et al. Liver Transpl. 2009 Oct;15(10):1325-9. doi: 10.1002/lt.21836. Liver Transpl. 2009. PMID: 19790137 Free article.

4

Is MELD fit enough?

O'Leary JG, Trotter JF. O'Leary JG, et al. Gastroenterology. 2011 Jun;140(7):1871-4. doi: 10.1053/j.gastro.2011.04.028. Epub 2011 Apr 24. Gastroenterology. 2011. PMID: 21521638 No abstract available.

5

Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men.

Lai JC, Verna EC, Brown RS Jr, O'Leary JG, Trotter JF, Forman LM, Duman JD, Foster RG, Stravitz RT, Terrault NA; Consortium to Study Health Outcomes in HCV Liver Transplant Recipients (CRUSH-C). Lai JC, et al. Hepatology. 2011 Aug;54(2):418-24. doi: 10.1002/hep.24390. Epub 2011 Jun 23. Hepatology. 2011. PMID: 21538434 Free PMC article.

6

Effect of tacrolimus on survival in hepatitis C-infected patients after liver transplantation.

O'Leary JG, Trotter JF, Neri MA, Jennings LW, McKenna GJ, Davis GL, Klintmalm GB. O'Leary JG, et al. Proc (Bayl Univ Med Cent). 2011 Jul;24(3):187-91. doi: 10.1080/08998280.2011.11928712. Proc (Bayl Univ Med Cent). 2011. PMID: 21738288 Free PMC article.

7

Limiting hepatitis C virus progression in liver transplant recipients using sirolimus-based immunosuppression.

McKenna GJ, Trotter JF, Klintmalm E, Onaca N, Ruiz R, Jennings LW, Neri M, O'Leary JG, Davis GL, Levy MF, Goldstein RM, Klintmalm GB. McKenna GJ, et al. Am J Transplant. 2011 Nov;11(11):2379-87. doi: 10.1111/j.1600-6143.2011.03767.x. Epub 2011 Oct 3. Am J Transplant. 2011. PMID: 21967703 Free article.

8

Recipient-donor race mismatch for African American liver transplant patients with chronic hepatitis C.

Saxena V, Lai JC, O'Leary JG, Verna EC, Brown RS Jr, Stravitz RT, Trotter JF, Krishnan K, Terrault NA; Consortium to Study Health Outcomes in HCV Liver Transplant Recipients. Saxena V, et al. Liver Transpl. 2012 May;18(5):524-31. doi: 10.1002/lt.22461. Liver Transpl. 2012. PMID: 22140019 Free PMC article.

9

Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort study.

Lai JC, O'Leary JG, Trotter JF, Verna EC, Brown RS Jr, Stravitz RT, Duman JD, Forman LM, Terrault NA; Consortium to Study Health Outcomes in HCV Liver Transplant Recipients (CRUSH-C). Lai JC, et al. Liver Transpl. 2012 May;18(5):532-8. doi: 10.1002/lt.23396. Liver Transpl. 2012. PMID: 22271671 Free PMC article.

10

Utilization of hepatitis C antibody-positive livers: genotype dominance is virally determined.

O'Leary JG, Neri MA, Trotter JF, Davis GL, Klintmalm GB. O'Leary JG, et al. Transpl Int. 2012 Aug;25(8):825-9. doi: 10.1111/j.1432-2277.2012.01498.x. Epub 2012 May 30. Transpl Int. 2012. PMID: 22643162 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

145 results

Search Page